Last Update 10 Mar 26

Fair value Increased 6.66%

L: Execution Discipline And Capital Allocation Will Support Steady Forward Return Profile

The analyst fair value estimate for Loblaw Companies has moved from CA$64.18 to CA$68.45, reflecting a series of upward price target revisions toward the CA$68 to CA$75 range as analysts factor in updated assumptions around discount rates, profit margins, and future P/E levels.

Analyst Commentary

Recent Street research on Loblaw Companies clusters around higher price targets in the CA$68 to CA$75 range, which aligns with the higher fair value estimate cited earlier. Analysts are refining their assumptions on discount rates, profit margins, and future P/E levels, and those updates are feeding directly into these revised targets.

Bullish Takeaways

Bullish analysts are concentrating price targets between CA$68 and CA$75. This supports the idea that Loblaw's earnings profile can justify valuations at the upper end of that band if execution stays on track.
The move to CA$75 targets from prior levels in the mid CA$60s reflects confidence that profit margins can hold at levels that support a higher multiple, rather than reverting to earlier assumptions.
Multiple firms converging around CA$70 indicates that, in their models, the current P/E and discount rate inputs still leave room for upside to their assessment of fair value.
The use of Buy and Outperform style ratings alongside higher targets suggests that, in bullish models, Loblaw's operating performance and cash generation are viewed as sufficient to support these elevated valuation ranges.

Bearish Takeaways

The presence of Market Perform style ratings, even with higher targets such as CA$68, indicates that some analysts see the current share price as closer to fully reflecting their assumptions on margins and P/E levels.
Price targets rising from the low to mid CA$60s into the high CA$60s still leave a gap compared with the top end CA$75 targets. This highlights uncertainty around how much valuation support Loblaw can sustain if assumptions on discount rates or profitability are tested.
The clustering of targets within a relatively tight CA$68 to CA$75 range indicates limited perceived room for error on execution. Minor disappointments on margins or earnings could challenge the higher end of those valuations.
Differences between Buy or Outperform style ratings and more neutral Market Perform style stances show that not all analysts are comfortable assigning the same upside potential, particularly when they factor in more conservative views on growth and returns.

What's in the News

Loblaw plans to spend CA$2.4b in 2026 to expand and renovate its store network, improve supply chain capabilities, and create an anticipated 9,700 retail and construction jobs across Canada, including 70 new stores and 191 store renovations, along with ongoing work on a roughly 1.2 million square foot automated distribution centre in Caledon, Ontario (Key Developments).
The 70 planned 2026 store openings include 34 Shoppers Drug Mart / Pharmaprix pharmacies and care clinics, and 31 No Frills and Maxi discount stores, adding more points of access for food and pharmacy offerings in Eastern Canada, Quebec, Ontario, and Western Canada (Key Developments).
Loblaw has announced a partnership with Ducks Unlimited Canada to support sustainable food systems, including work with grain growers and livestock producers to rehabilitate marginal cropland, establish perennial cover, and implement farm practices aimed at soil health, biodiversity, and farm resilience (Key Developments).
The Ducks Unlimited Canada collaboration ties into programs such as the Marginal Areas Program, Forage Conversion, and Winter Cereals initiatives, which are designed to convert low yield acres to perennial forage and support ag environmental outcomes like water absorption and beneficial insect habitat (Key Developments).
Loblaw announced a private placement of CA$500,000,000 in senior unsecured notes bearing interest at 4.387% per year and maturing on June 16, 2035, with ratings of BBB (high) with a Positive trend from Morningstar DBRS and BBB+ from Standard & Poor's, and subsequently closed the transaction on December 16, 2025 (Key Developments).

Valuation Changes

Fair Value Estimate has risen from CA$64.18 to CA$68.45, a move of around 6.7%, bringing it closer to the upper end of recent analyst target ranges.
Discount Rate has fallen slightly from 6.63% to about 6.55%, which modestly lifts the present value of projected cash flows in updated models.
Revenue Growth has been trimmed from roughly 3.86% to about 3.30%, signalling a more cautious stance on assumptions for top line expansion.
Net Profit Margin has increased from about 3.50% to roughly 3.95%, pointing to higher expected earnings efficiency on each CA$ of sales.
Future P/E has been reduced from about 35.1x to roughly 32.8x, indicating a slightly lower multiple applied to earnings in the newer valuation work.

1 view

Key Takeaways

Expansion of pharmacy clinics, healthcare services, and digital transformation boosts customer engagement, pharmacy traffic, and overall sales growth.
ESG initiatives, private label strength, and supply chain automation drive higher margins, brand loyalty, and reduced operational costs.
Accelerating online shift, intense digital competition, margin pressures, regulatory scrutiny, supply chain disruption, and execution risks from heavy investment threaten Loblaw's long-term profitability and growth.

Catalysts

About Loblaw Companies

A food and pharmacy company, provides grocery, pharmacy and healthcare services, health and beauty products, apparel, general merchandise, financial services, and wireless mobile products and services in Canada and the United States.What are the underlying business or industry changes driving this perspective?

Loblaw's integrated expansion of in-store pharmacy clinics and enhanced primary care services is capitalizing on rising healthcare needs and an aging population, driving higher pharmacy traffic, prescription volumes, and cross-selling opportunities-positively impacting same-store sales and net margins.
The push towards ESG initiatives, local sourcing, and the Buy Canadian trend is strengthening brand loyalty and supporting premium pricing and private label sales, which anchors gross margins and lowers competitive churn risk.
Ongoing investments in AI-driven supply chain optimization and retail automation are reducing logistics, inventory, and labor costs, directly benefiting gross and operating margins over time.
Accelerated rollout of new discount and hard-discount stores, along with strong urban and multicultural growth banners like TNT, positions Loblaw to maintain and grow market share as consumers shift toward value and home-based food consumption-fueling sustainable top-line revenue growth.
Rapid digital transformation through PC Optimum loyalty and personalized e-commerce offerings increases customer engagement, basket size, and data-driven upselling, supporting both same-store sales and higher earnings per share.

Loblaw Companies Earnings and Revenue Growth

Loblaw Companies Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Loblaw Companies's revenue will grow by 4.1% annually over the next 3 years.
Analysts assume that profit margins will shrink from 3.6% today to 3.5% in 3 years time.
Analysts expect earnings to reach CA$2.4 billion (and earnings per share of CA$2.08) by about September 2028, up from CA$2.2 billion today.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 34.1x on those 2028 earnings, up from 30.6x today. This future PE is greater than the current PE for the CA Consumer Retailing industry at 20.3x.
Analysts expect the number of shares outstanding to decline by 1.21% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 6.33%, as per the Simply Wall St company report.

Loblaw Companies Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

The accelerating shift to online grocery and e-commerce, coupled with intensified competition from global digital retailers (e.g., Amazon, Walmart), threatens Loblaw's traditional brick-and-mortar advantage and could erode store traffic and market share if e-commerce adoption or digital innovation lags, ultimately pressuring long-term revenue growth.
Margin compression risk persists as Loblaw's continued expansion of hard discount stores and private label offerings targets value-seeking customers but relies on lower-price, lower-margin formats-potentially offsetting scale benefits and hampering future net margin growth if industry-wide price deflation intensifies.
Heightened regulatory and ESG scrutiny-particularly around food pricing, tariffs, and sustainability-introduces compliance cost uncertainties, reputational risk (noted by recent media and political attention on grocer pricing), and potential regulatory headwinds that could increase SG&A expense and restrict net earnings growth.
Persistent global supply chain volatility, supplier cost inflation, and ongoing tariff impacts expose Loblaw to inventory shortages, higher input costs, and lost sales-especially since only a minority of supplier cost increases are tariff-related, with many linked to broader inflation or global vendor demands-negatively affecting gross margins and cash flow reliability.
Heavy investment in store expansion, automated distribution centers, and digital transformation carries execution risks and creates P&L drag during ramp-up periods; if consumer demand or macro conditions weaken, there is a risk that fixed cost absorption and operating leverage do not materialize as expected, constraining earnings and return on capital.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of CA$59.477 for Loblaw Companies based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CA$66.75, and the most bearish reporting a price target of just CA$39.0.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be CA$69.5 billion, earnings will come to CA$2.4 billion, and it would be trading on a PE ratio of 34.1x, assuming you use a discount rate of 6.3%.
Given the current share price of CA$56.79, the analyst price target of CA$59.48 is 4.5% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Loblaw Companies?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Integrated Healthcare And Retail Automation Will Unlock Value